Both mitochondrial dysfunction and impaired adiponectin/AdipoR1 signaling are thought to contribute to tissue damage in diabetes complication organs, including diabetic cardiomyopathy, diabetic nephropathy and non-alcoholic fatty liver disease (30). Here, ADIPOQ is linked to metabolic dysfunction-associated steatotic liver disease.